Bayawa, Kyle Jesper R.
HRN: 21-15-35 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
11/21/2024
METRONIDAZOLE 125MG/5ML, 60ML (BOT)
11/21/2024
12/05/2024
PO
4ml
TID
Amoebiasis
Waiting Final Action
Indication: ProphylaxisEmpiric Type of Infection: Intra-abdominal Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes